tiprankstipranks
Advertisement
Advertisement

GB:0QCV Stock Latest News

AbbVie price target raised to $249 from $242 at Guggenheim
The FlyAbbVie price target raised to $249 from $242 at Guggenheim
3h ago
ABBV
Trump Trade: AbbVie sues White House over discount drug program
PremiumThe Fly
Trump Trade: AbbVie sues White House over discount drug program
23h ago
NNE
SPY
AbbVie sues White House over discount drug program, Axios says
PremiumThe Fly
AbbVie sues White House over discount drug program, Axios says
2d ago
ABBV
AbbVie price target lowered to $240 from $250 at Cantor Fitzgerald
PremiumThe Fly
AbbVie price target lowered to $240 from $250 at Cantor Fitzgerald
2d ago
ABBV
AbbVie should be bought on recent selloff, says JPMorgan
PremiumThe Fly
AbbVie should be bought on recent selloff, says JPMorgan
3d ago
ABBV
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
PremiumThe FlyAbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
4d ago
ABBV
CHRO
Oruka Therapeutics price target raised to $125 from $60 at Guggenheim
Premium
The Fly
Oruka Therapeutics price target raised to $125 from $60 at Guggenheim
4d ago
ABBV
ORKA
AbbVie: Resilient Core, Growing Aesthetics, and Strategic Acquisitions Underpin Buy Rating
Premium
Ratings
AbbVie: Resilient Core, Growing Aesthetics, and Strategic Acquisitions Underpin Buy Rating
9d ago
ABBV
AbbVie: Immunology Strength, Strategic Acquisitions, and Patent Headwind Execution Support Buy Rating
PremiumRatings
AbbVie: Immunology Strength, Strategic Acquisitions, and Patent Headwind Execution Support Buy Rating
11d ago
ABBV
AbbVie call volume above normal and directionally bullish
PremiumThe Fly
AbbVie call volume above normal and directionally bullish
14d ago
ABBV
AbbVie named Official Pharmaceutical Partner of Major League Baseball
PremiumThe Fly
AbbVie named Official Pharmaceutical Partner of Major League Baseball
17d ago
ABBV
AbbVie Stock Slides as Insider Selling Spooks Investors
PremiumWeekend Updates
AbbVie Stock Slides as Insider Selling Spooks Investors
20d ago
ABBV
AbbVie, Alloy Therapeutics enter agreement to develop antibody platform
PremiumThe FlyAbbVie, Alloy Therapeutics enter agreement to develop antibody platform
24d ago
ABBV
AbbVie’s Allergan Aesthetics launches Skin Quality Index
Premium
The Fly
AbbVie’s Allergan Aesthetics launches Skin Quality Index
25d ago
ABBV
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
Premium
Ratings
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
1M ago
ABBV
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
1M ago
ABBV
AbbVie Completes $8 Billion Senior Notes Financing Offering
PremiumCompany Announcements
AbbVie Completes $8 Billion Senior Notes Financing Offering
1M ago
8K
ABBV
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
PremiumThe Fly
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
1M ago
ABBV
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
1M ago
ABBV
AbbVie Announces $7.5 Billion Senior Notes Offering
PremiumCompany AnnouncementsAbbVie Announces $7.5 Billion Senior Notes Offering
1M ago
8K
ABBV
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
Premium
The Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
1M ago
PFE
ABBV
AbbVie initiated with an Outperform at RBC Capital
Premium
The Fly
AbbVie initiated with an Outperform at RBC Capital
1M ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >